Dapoxetine N-Oxide | CAS 1346603-24-4 - Request Quote
Dapoxetine N-Oxide
| SZ CAT No: | SZ-D070005 |
| CAS No | 1346603-24-4 |
| Mol.F. | C21H23NO2 |
| Mol.Wt. | 321.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dapoxetine N-Oxide is chemically (S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine oxide. Dapoxetine N-Oxide is supplied with detailed characterization data compliant with regulatory guideline. Dapoxetine N-Oxide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dapoxetine .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1346603-24-4
Purchase 1346603-24-4
Order 1346603-24-4
Enquire 1346603-24-4
price of 1346603-24-4
1346603-24-4 Supplier
1346603-24-4 Manufacturer
1346603-24-4 Exporter
buy high quality Dapoxetine N-Oxide
Purchase Dapoxetine N-Oxide
Dapoxetine N-Oxide suppliers
Dapoxetine N-Oxide manufacturers
Dapoxetine N-Oxide price
Order Dapoxetine N-Oxide
Enquire Dapoxetine N-Oxide
Dapoxetine N-Oxide cost
Dapoxetine N-Oxide Supplier
Dapoxetine N-Oxide Distributor
Dapoxetine N-Oxide for Method Validation
Dapoxetine Reference Standard
Dapoxetine N-Oxide for ANDA Filing
Dapoxetine N-Oxide for Forced Degradation Studies
Dapoxetine N-Oxide Identification Standards
Dapoxetine N-Oxide for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


